
Berkshire's $330M Bending Spoons Bet: Its Name Was Worth More Than Its Cash #216
Berkshire Hathaway invested a further $330M in Bending Spoons after its $600M IPO investment, buying 10 million new shares at $33, about 13% below the prior close, and the stock closed at $53.46, up 41%. We discuss the Berkshire effect: Berkshire's name was worth more than its cash, and the market priced it in within a day. Bending Spoons buys, improves and holds companies and says it has never sold a material business, so this is a permanent owner buying a permanent owner, now at 37x EBITDA. Then biotech: Nouscom's €120M Series D brings together corporate VCs like M Ventures and Angelini, public money from the European Investment Bank and CDP Venture Capital, and specialist biotech funds like 5AM Ventures and Andera Partners. Even Healthcare, led by an Italian founder in India, raised a €50M Series B from Khosla Ventures and Alpha Wave to put membership, clinics and hospitals under one company. We close on the Q3 data: about 1.3B invested year-to-date against 855M, Series B rounds up from 7 to 11 and Series C+ from 3 to 7, but the number of rounds down 31%. Niccolò's worry: if the seed base shrinks without a flight to quality, there will be fewer companies to raise the B, C and D rounds of the future. Niccolò's newsletter: http://dealflowit.niccolosanarico.com/ Watch on Youtube: https://www.youtube.com/@giacomomollo Listen to all episodes on audio: Spotify: https://spoti.fi/3fVynsQ Google Podcast: https://bit.ly/3thf9RC Apple Podcast: https://apple.co/3Elhykq Amazon Music: https://shorturl.at/9Dtd9 Get in touch: Instagram: https://www.instagram.com/giacxxx Twitter: https://twitter.com/giacomomollo Email: giacomo@in3.ventures #venturecapital #italy #startup




